iBio, Inc. (IBIO)
1.73
-0.09 (4.95%)
Upcoming Events
Latest Headlines
Raymond James Starts iBio, Inc. (IBIO) at Outperform
June 8, 2026 6:07 AM - StreetInsider
B.Riley Starts iBio, Inc. (IBIO) at Buy
June 5, 2026 8:36 AM - StreetInsider
iBio to Participate in Upcoming Healthcare Investor Conferences
June 2, 2026 4:01 PM - StreetInsider
iBio begins phase 1 trial of obesity drug IBIO-600
June 2, 2026 7:00 AM - StreetInsider
iBio Becomes a Clinical-Stage Company with First Participant Dosed in Phase 1 Clinical Trial of IBIO-600 in Adults with Obesity
June 2, 2026 7:00 AM - StreetInsider
Form 4 iBio, Inc. For: May 18 Filed by: Stoner Elizabeth
May 19, 2026 7:45 AM - SEC Filing
Form SCHEDULE 13G/A iBio, Inc. Filed by: Logos Global Management LP
May 15, 2026 6:42 PM - SEC Filing
Form SCHEDULE 13G/A iBio, Inc. Filed by: Point72 Asset Management, L.P.
May 15, 2026 4:27 PM - SEC Filing
Form SCHEDULE 13G/A iBio, Inc. Filed by: EcoR1 Capital, LLC
May 15, 2026 2:26 PM - SEC Filing
Form SCHEDULE 13G/A iBio, Inc. Filed by: Cormorant Asset Management, LP
May 15, 2026 1:22 PM - SEC Filing
Form SCHEDULE 13G iBio, Inc. Filed by: Sirenia Capital Management LP
May 15, 2026 8:16 AM - SEC Filing
Form 3 iBio, Inc. For: May 07 Filed by: Stoner Elizabeth
May 15, 2026 7:01 AM - SEC Filing
Form SCHEDULE 13G/A iBio, Inc. Filed by: Affinity Asset Advisors, LLC
May 14, 2026 4:12 PM - SEC Filing
iBio, Inc. (IBIO) Misses Q3 EPS by 7c
May 12, 2026 4:43 PM - StreetInsider
Form SCHEDULE 13G/A iBio, Inc. Filed by: Frazier Life Sciences Public Fund, L.P.
May 12, 2026 4:32 PM - SEC Filing
Form 10-Q iBio, Inc. For: Mar 31
May 12, 2026 4:19 PM - SEC Filing
Form 8-K iBio, Inc. For: May 12
May 12, 2026 4:17 PM - SEC Filing
iBio Reports Q3 Fiscal Year 2026 Financial Results and Provides Corporate Update
May 12, 2026 4:05 PM - StreetInsider
Form 8-K iBio, Inc. For: May 07
May 8, 2026 4:17 PM - SEC Filing
iBio names Elizabeth Stoner to board of directors
May 8, 2026 7:15 AM - StreetInsider
iBio Appoints Distinguished Biotech Leader, Elizabeth Stoner, to its Board of Directors
May 8, 2026 7:15 AM - Globe NewsWire
Form 424B3 iBio, Inc.
April 29, 2026 9:12 AM - SEC Filing
Form 8-K/A iBio, Inc. For: Apr 08
April 17, 2026 5:14 PM - SEC Filing
Form 8-K iBio, Inc. For: Apr 08
April 8, 2026 9:03 AM - SEC Filing
iBio receives Australian approval for Phase 1 trial of IBIO-600
April 8, 2026 7:00 AM - StreetInsider
iBio Received Regulatory Clearance to Initiate Its Phase 1 Clinical Trial of IBIO-600 in Australia
April 8, 2026 7:00 AM - Globe NewsWire
Form 4 iBio, Inc. For: Mar 26 Filed by: Banjak Marc
March 27, 2026 4:06 PM - SEC Filing
Leerink Partners on iBio, Inc. (IBIO): selloff on WVE data 'overreaction'
March 26, 2026 2:46 PM - StreetInsider
Form 4 iBio, Inc. For: Mar 19 Filed by: Duran Felipe
March 23, 2026 7:31 AM - SEC Filing
Form 4 iBio, Inc. For: Mar 19 Filed by: Brenner Martin
March 23, 2026 7:30 AM - SEC Filing
Jones Trading Reiterates Buy Rating on iBio, Inc. (IBIO) amid pipeline expansion
March 18, 2026 4:47 PM - StreetInsider
iBio to Provide an Update on Cardiopulmonary Program Targeting Pulmonary Hypertension Associated with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)
March 16, 2026 4:30 PM - StreetInsider
Full Article List
